Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye

par Sambursky R
Publié 2016

A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca

par Jerkins GW, Pattar GR, Kannarr SR
Publié 2020

Cyclosporine Biosynthesis in <italic toggle="yes">Tolypocladium inflatum</italic> Benefits Fungal Adaptation to the Environment

par Xiuqing Yang, Peng Feng, Ying Yin, Kathryn Bushley, Joseph W. Spatafora, Chengshu Wang
Publié 2018

In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug

par Rasul A, Imran Khan M, Rehman MU, Abbas G, Aslam N, Ahmad S, Abbas K, Akhtar Shah P, Iqbal M, Ahmed Al Subari AM, Shaheer T, Shah S
Publié 2020

Cyclosporin A-treated Dendritic Cells may affect the outcome of organ transplantation by decreasing CD4+CD25+ regulatory T cell proliferation

par Pino-Lagos,Karina, Michea,Paula, Sauma,Daniela, Alba,Andrea, Morales,Jorge, Bono,María Rosa, Fierro,Alberto, Rosemblatt,Mario
Publié 2010

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

par Sheppard J, Bergmann M, Schechter BA, Luchs J, Ogundele A, Karpecki P
Publié 2021

Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease

par White DE, Zhao Y, Jayapalan H, Machiraju P, Periyasamy R, Ogundele A
Publié 2020

Febrile Ulceronecrotic Mucha-Habermann Disease: A Rare Case Report and Review of Cases Treated With Oral Cyclosporine

par Apasee Sooksamran, Poonnawis Sudtikoonaseth, Praneet Sajjachareonpong, Tanongkiet Tienthavorn
Publié 2021

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease

par White DE, Zhao Y, Jayapalan H, Machiraju P, Periyasamy R, Ogundele A
Publié 2020

Effect of Erythromycin on the Intestinal Transport of Cyclosporine

par P Zakeri Milani, S Damani, Z Islambulchilar, M Mehtari, H Valizadeh
Publié 2009

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of...

par Burade V, Zalawadia R, Patel A, Ogundele A
Publié 2020

Cyclosporine A Induces Cardiac Developmental Toxicity in Zebrafish by Up-Regulation of Wnt Signaling and Oxidative Stress

par Mengqi Wan, Ling Huang, Jieping Liu, Fasheng Liu, Guilan Chen, Huiwen Ni, Guanghua Xiong, Xinjun Liao, Huiqiang Lu, Juhua Xiao, Qiang Tao, Zigang Cao
Publié 2021

Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2

par C. Yoonhee Ryder, BS, Elisabeth A. Pedersen, MD, PhD, Jennifer B. Mancuso, MD
Publié 2021

A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments

par Periman LM, Mah FS, Karpecki PM
Publié 2020

Effect of Cyclosporine 0.09% Treatment on Accuracy of Preoperative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery

par Hovanesian JA, Berdy GJ, Epitropoulos A, Holladay JT
Publié 2021

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye

par White DE, Zhao Y, Ogundele A, Fulcher N, Acs A, Moore-Schiltz L, Karpecki PM
Publié 2019

Thymodepressin—Unforeseen Immunosuppressor

par Vladislav I. Deigin, Julia E. Vinogradova, Dmitry L Vinogradov, Marina S. Krasilshchikova, Vadim T. Ivanov
Publié 2021

Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program

par Pisella P, Labetoulle M, Doan S, Cochener-Lamard B, Amrane M, Ismail D, Creuzot-Garcher C, Baudouin C
Publié 2018

Colon-targeted delivery of cyclosporine A using dual-functional Eudragit&reg;&nbsp;FS30D/PLGA&nbsp;nanoparticles ameliorates murine experimental colitis

par Naeem M, Bae J, Oshi MA, Kim M, Moon HR, Lee BL, Im E, Jung Y, Yoo J
Publié 2018

A meta-analysis of cyclosporine treatment for Stevens&ndash;Johnson syndrome/toxic epidermal necrolysis

par Ng QX, De Deyn MLZQ, Venkatanarayanan N, Ho CYX, Yeo WS
Publié 2018